Back to Search
Start Over
Table S5 from A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation–Positive Solid Tumors
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Adverse events, suspected to be study drug related, reported by primary system organ class
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....516d7fe5426956d961efcda02b459911
- Full Text :
- https://doi.org/10.1158/1078-0432.22472555